These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1401838)

  • 1. Fatal torsade de pointes occurring in a patient receiving intravenous vasopressin and nitroglycerin.
    Stein LB; Dabezies MA; Silverman M; Brozena SC
    J Clin Gastroenterol; 1992 Sep; 15(2):171-4. PubMed ID: 1401838
    [No Abstract]   [Full Text] [Related]  

  • 2. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance.
    Faigel DO; Metz DC; Kochman ML
    Am J Gastroenterol; 1995 May; 90(5):822-4. PubMed ID: 7733096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scrotal ischemia after intravenous vasopressin therapy for hemorrhagic esophageal varices.
    Chang FY; Cheng JT; Lai KH; Lee SD; Tsai YT
    N Y State J Med; 1989 Oct; 89(10):583-4. PubMed ID: 2608219
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitroglycerin use in variceal hemorrhage.
    Dattani BH; Troyer SD; Truitt CA
    Ann Pharmacother; 1994 Feb; 28(2):206-8. PubMed ID: 8173137
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous nitroglycerin to improve coronary blood flow and left ventricular performance during vasopressin therapy.
    Bush HL; Nabseth DC
    Surg Forum; 1979; 30():226-8. PubMed ID: 120016
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular arrhythmia induced by vasopressin: torsade de pointes related to vasopressin-induced bradycardia.
    Eden E; Teirstein A; Wiener I
    Mt Sinai J Med; 1983; 50(1):49-51. PubMed ID: 6601760
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation and revision of a vasopressin/nitroglycerin protocol for use in variceal bleeding.
    Burns SM; Martin M; Merrill P; Luer J; Stone DD
    Am J Crit Care; 1993 May; 2(3):202-7. PubMed ID: 8364671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdomyolysis associated with the use of intravenous vasopressin.
    Pierce ST; Nickl N
    Am J Gastroenterol; 1993 Mar; 88(3):424-7. PubMed ID: 8438851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous reaction to vasopressin.
    Lemlich G; Di Grandi S; Szaniawski WK
    Cutis; 1996 May; 57(5):330-2. PubMed ID: 8726714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP/NTG therapy in the patient with variceal bleeding.
    Burns SM; Martin MJ
    Crit Care Nurse; 1990 Oct; 10(9):42-9. PubMed ID: 2121418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of vasopressin in the management of bleeding esophageal varices.
    Schweitzer EJ; Kerr JC; Swan KG
    Am Surg; 1982 Nov; 48(11):558-62. PubMed ID: 6983321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsade de pointes in a patient receiving intravenous vasopressin.
    Mauro VF; Bingle JF; Ginn SM; Jafri FM
    Crit Care Med; 1988 Feb; 16(2):200-1. PubMed ID: 3257726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local gangrene: a complication of peripheral Pitressin therapy for bleeding esophageal varices.
    Greenwald RA; Rheingold OJ; Chiprut RO; Rogers AI
    Gastroenterology; 1978 Apr; 74(4):744-6. PubMed ID: 305380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin induction of ventricular ectopy.
    Fitz JD
    Arch Intern Med; 1982 Mar; 142(3):644. PubMed ID: 6978117
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-pharmacological case (2). Bradycardia and ventricular tachycardia of the torsades de pointes type as a side effect of vasopressin: 3 case reports].
    Kupferschmidt H; Meier CH; Sulzer M; Meier PJ; Bühler H
    Praxis (Bern 1994); 1996 Mar; 85(11):340-3. PubMed ID: 8643894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of nitroglycerin to vasopressin therapy for the treatment of bleeding esophageal varices.
    Parsons DG
    Hepatology; 1987; 7(4):801. PubMed ID: 3111969
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial.
    Bosch J; Groszmann RJ; García-Pagán JC; Terés J; García-Tsao G; Navasa M; Mas A; Rodés J
    Hepatology; 1989 Dec; 10(6):962-8. PubMed ID: 2511136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage.
    Gimson AE; Westaby D; Hegarty J; Watson A; Williams R
    Hepatology; 1986; 6(3):410-3. PubMed ID: 3086204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral nipple necrosis after intravenous vasopressin therapy.
    Reddy KR; Iskandarani M; Jeffers L; Schiff ER
    Arch Intern Med; 1984 Apr; 144(4):835-6. PubMed ID: 6608931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.
    Silvain C; Carpentier S; Sautereau D; Czernichow B; Métreau JM; Fort E; Ingrand P; Boyer J; Pillegand B; Doffël M
    Hepatology; 1993 Jul; 18(1):61-5. PubMed ID: 8325622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.